Structural basis of modified-DNA inhibitors that competitively restrict DNA-mutating (C-to-U) activity of innate-immune system enzyme APOBEC3A hijacked by cancer cells to evolve therapeutic resistance

Abstract only

Saved in:

Bibliographic Details
Published in	Acta crystallographica. Section A, Foundations and advances Vol. 79; no. a2; p. C692
Main Authors	Jameson, G. B., Harjes, S., Kurup, H. M., Bayarjargal, M., Filitcheva, J., Su, Y., Hale, T. K., Filichev, V. V., Harjes, E., Rieffer, A. E., Harris, R. S.
Format	Journal Article
Language	English
Published	22.08.2023
Online Access	Get full text

Loading…